Transaction Details

Footnotes

The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $17.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. | The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities. | The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. | The option was granted on November 10, 2015 and is fully vested and exercisable as of the transaction date. | The option was granted on July 7, 2021 and is fully vested and exercisable as of the transaction date.